Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT03150004 · TERMINATED
Trial details
- NCT number
- NCT03150004
- Sponsor
- Medical College of Wisconsin
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-14
- Primary completion
- 2025-03-14
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.